{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T21:13:50Z","timestamp":1788642830107,"version":"build-2803163510"},"reference-count":64,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.nmd.2021.07.400","type":"journal-article","created":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T02:39:35Z","timestamp":1635820775000},"page":"943-954","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Congenital myasthenic syndromes: where do we go from here?"],"prefix":"10.1016","volume":"31","author":[{"given":"Sithara","family":"Ramdas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9395-7132","authenticated-orcid":false,"given":"David","family":"Beeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.nmd.2021.07.400_bib0001","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1474-4422(14)70201-7","article-title":"Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment","volume":"14","author":"Engel","year":"2015","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.nmd.2021.07.400_bib0002","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/WCO.0000000000000736","article-title":"The congenital myasthenic syndromes: expanding genetic and phenotypic spectrums and refining treatment strategies","volume":"32","author":"Vanhaesebrouck","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.nmd.2021.07.400_bib0003","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00415-011-6194-7","article-title":"Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis","volume":"259","author":"Pevzner","year":"2012","journal-title":"J Neurol"},{"issue":"42","key":"10.1016\/j.nmd.2021.07.400_bib0004","doi-asserted-by":"crossref","first-page":"21228","DOI":"10.1073\/pnas.1908284116","article-title":"Muscle acetylcholine receptor conversion into chloride conductance at positive potentials by a single mutation","volume":"116","author":"Cetin","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.nmd.2021.07.400_bib0005","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3390\/ijms19061677","article-title":"The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes","volume":"19","author":"Rodr\u00edguez Cruz","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.nmd.2021.07.400_bib0006","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1073\/pnas.98.4.2017","article-title":"Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans","volume":"98","author":"Ohno","year":"2001","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1016\/j.nmd.2021.07.400_bib0007","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ajhg.2016.06.033","article-title":"Impaired presynaptic high-affinity choline transporter causes a congenital myasthenic syndrome with episodic apnea","volume":"99","author":"Bauch\u00e9","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.nmd.2021.07.400_bib0008","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1212\/WNL.0000000000003179","article-title":"Variants in SLC18A3, vesicular acetylcholine transporter, cause congenital myasthenic syndrome","volume":"87","author":"O'Grady","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2021.07.400_bib0009","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nmd.2020.10.006","article-title":"Presynaptic congenital myasthenic syndrome due to three novel mutations in SLC5A7 encoding the sodium-dependant high-affinity choline transporter","volume":"31","author":"Rodr\u00edguez Cruz","year":"2021","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.nmd.2021.07.400_bib0010","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ajhg.2014.08.007","article-title":"Synaptotagmin 2 mutations cause an autosomal-dominant form of lambert-eaton myasthenic syndrome and nonprogressive motor neuropathy","volume":"95","author":"Herrmann","year":"2014","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2021.07.400_bib0011","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1212\/NXG.0000000000000105","article-title":"Loss of MUNC13-1 function causes microcephaly, cortical hyperexcitability, and fatal myasthenia","volume":"2","author":"Engel","year":"2016","journal-title":"Neurol Genet"},{"issue":"4","key":"10.1016\/j.nmd.2021.07.400_bib0012","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ana.24905","article-title":"Homozygous mutations in VAMP1 cause a presynaptic congenital myasthenic syndrome","volume":"81","author":"Salpietro","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2021.07.400_bib0013","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1212\/WNL.0000000000001079","article-title":"Mutant SNAP25B causes myasthenia, cortical hyperexcitability, ataxia, and intellectual disability","volume":"83","author":"Shen","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2021.07.400_bib0014","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ejpn.2009.09.009","article-title":"Long-term follow-up in patients with congenital myasthenic syndrome due to CHAT mutations","volume":"14","author":"Schara","year":"2010","journal-title":"Eur J Paediatr Neurol"},{"issue":"9","key":"10.1016\/j.nmd.2021.07.400_bib0015","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/humu.22823","article-title":"Choline acetyltransferase mutations causing congenital myasthenic syndrome: molecular findings and genotype-phenotype correlations","volume":"36","author":"Arredondo","year":"2015","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2021.07.400_bib0016","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1212\/WNL.0000000000003720","article-title":"Vesicular acetylcholine transporter defect underlies devastating congenital myasthenia syndrome","volume":"88","author":"Aran","year":"2017","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.nmd.2021.07.400_bib0017","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1093\/brain\/awx249","article-title":"Choline transporter mutations in severe congenital myasthenic syndrome disrupt transporter localization","volume":"140","author":"Wang","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2021.07.400_bib0018","first-page":"98","article-title":"Snare-mediated membrane fusion","volume":"2","author":"Chen","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.nmd.2021.07.400_bib0019","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1212\/WNL.0000000000001079","article-title":"Mutant SNAP25B causes myasthenia, cortical hyperexcitability, ataxia, and intellectual disability","volume":"83","author":"Shen","year":"2014","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nmd.2021.07.400_bib0020","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ana.24905","article-title":"Homozygous mutations in VAMP1 cause a presynaptic congenital myasthenic syndrome","volume":"81","author":"Salpietro","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2021.07.400_bib0021","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1212\/NXG.0000000000000105","article-title":"Loss of MUNC13-1 function causes microcephaly, cortical hyperexcitability, and fatal myasthenia","volume":"2","author":"Engel","year":"2016","journal-title":"Neurol Genet"},{"issue":"3","key":"10.1016\/j.nmd.2021.07.400_bib0022","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ajhg.2014.08.007","article-title":"Synaptotagmin 2 mutations cause an autosomal-dominant form of lambert-eaton myasthenic syndrome and nonprogressive motor neuropathy","volume":"95","author":"Herrmann","year":"2014","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2021.07.400_bib0023","first-page":"1","article-title":"Identification of mutations in the MYO9A gene in patients with congenital myasthenic syndrome","author":"O'Connor","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2021.07.400_bib0024","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/gim.2017.74","article-title":"PREPL deficiency: delineation of the phenotype and development of a functional blood assay","volume":"20","author":"Regal","year":"2018","journal-title":"Genet Med"},{"issue":"14","key":"10.1016\/j.nmd.2021.07.400_bib0025","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1212\/WNL.0000000000000295","article-title":"PREPL deficiency with or without cystinuria causes a novel myasthenic syndrome","volume":"82","author":"R\u00e9gal","year":"2014","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nmd.2021.07.400_bib0026","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ajhg.2013.03.009","article-title":"Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined d-2- and l-2-hydroxyglutaric aciduria","volume":"92","author":"Nota","year":"2013","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.nmd.2021.07.400_bib0027","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JND-140021","article-title":"Mutations in the mitochondrial citrate carrier SLC25A1 are associated with impaired neuromuscular transmission","volume":"1","author":"Chaouch","year":"2014","journal-title":"J Neuromuscul Dis"},{"issue":"16","key":"10.1016\/j.nmd.2021.07.400_bib0028","doi-asserted-by":"crossref","first-page":"9654","DOI":"10.1073\/pnas.95.16.9654","article-title":"Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme","volume":"95","author":"Ohno","year":"1998","journal-title":"Proc Natl Acad Sci USA."},{"issue":"3","key":"10.1016\/j.nmd.2021.07.400_bib0029","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/brain\/awm325","article-title":"Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes","volume":"131","author":"Mihaylova","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2021.07.400_bib0030","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/jmg.2008.063693","article-title":"Mutations in LAMB2 causing a severe form of synaptic congenital myasthenic syndrome","volume":"46","author":"Maselli","year":"2009","journal-title":"J Med Genet"},{"issue":"9","key":"10.1016\/j.nmd.2021.07.400_bib0031","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/humu.21304","article-title":"Mutations in the human laminin \u03b22 (LAMB2) gene and the associated phenotypic spectrum","author":"Matejas","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2021.07.400_bib0032","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/ajmg.a.38291","article-title":"Presynaptic congenital myasthenic syndrome with a homozygous sequence variant in LAMA5 combines myopia, facial tics, and failure of neuromuscular transmission","author":"Maselli","year":"2017","journal-title":"Am J Med Genet"},{"issue":"6","key":"10.1016\/j.nmd.2021.07.400_bib0033","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.ajhg.2015.10.017","article-title":"Congenital myasthenic syndrome type is caused by mutations in COL13A1, encoding the atypical non-fibrillar collagen type XIII alpha-1 chain","volume":"97","author":"Logan","year":"2015","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.nmd.2021.07.400_bib0034","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/brain\/awz107","article-title":"The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations","volume":"142","author":"Rodr\u00edguez Cruz","year":"2019","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.nmd.2021.07.400_bib0035","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/brain\/124.7.1362","article-title":"Endplate gamma- and epsilon-subunit mRNA levels in AChR deficiency syndrome due to epsilon-subunit null mutations","volume":"124","author":"Croxen","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2021.07.400_bib0036","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/ana.410400521","article-title":"End-plate acetylcholine receptor deficiency due to nonsense mutations in the \u025b subunit","volume":"40","author":"Engel","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2021.07.400_bib0037","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0896-6273(00)80289-5","article-title":"Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor epsilon subunit","volume":"17","author":"Ohno","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.nmd.2021.07.400_bib0038","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.nmd.2011.08.002","article-title":"Clinical features in a series of fast channel congenital myasthenia syndrome","volume":"22","author":"Palace","year":"2012","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.nmd.2021.07.400_bib0039","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s00415-011-6204-9","article-title":"A retrospective clinical study of the treatment of slow-channel congenital myasthenic syndrome","volume":"259","author":"Chaouch","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2021.07.400_bib0040","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.24389","article-title":"Defective fast inactivation recovery of Na(v)1.4 in congenital myasthenic syndrome","volume":"77","author":"Arnold","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2021.07.400_bib0041","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1093\/brain\/awu160","article-title":"Agrin mutations lead to a congenital myasthenic syndrome with distal muscle weakness and atrophy","volume":"137","author":"Nicole","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2021.07.400_bib0042","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/jamaneurol.2015.0853","article-title":"Impaired synaptic development, maintenance, and neuromuscular transmission in LRP4-related myasthenia","volume":"72","author":"Selcen","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.nmd.2021.07.400_bib0043","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1002\/ajmg.a.38707","article-title":"Recessive variants of MuSK are associated with late onset CMS and predominant limb girdle weakness","volume":"176","author":"Owen","year":"2018","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.nmd.2021.07.400_bib0044","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/brain\/awm072","article-title":"Clinical features of the DOK7 neuromuscular junction synaptopathy","volume":"130","author":"Palace","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2021.07.400_bib0045","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1212\/WNL.0b013e3181ae7cbc","article-title":"Myasthenic syndrome due to defects in rapsyn: clinical and molecular findings in 39 patients","volume":"73","author":"Milone","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2021.07.400_bib0046","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajhg.2012.05.022","article-title":"Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates","volume":"91","author":"Belaya","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"8","key":"10.1016\/j.nmd.2021.07.400_bib0047","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s00415-017-8569-x","article-title":"Mutations in GFPT1- related congenital myasthenic syndromes are associated with synaptic morphological defects and underlie a tubular aggregate myopathy with synaptopathy","volume":"264","author":"Bauche","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2021.07.400_bib0048","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/humu.10239","article-title":"Deficiency of UDP-GlcNAc:dolichol phosphate N-acetylglucosamine-1 phosphate transferase (DPAGT1) causes a novel congenital disorder of glycosylation type Ij","volume":"22","author":"Wu","year":"2003","journal-title":"Hum. Mutat"},{"key":"10.1016\/j.nmd.2021.07.400_bib0049","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ajhg.2013.05.009","article-title":"Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of alpha-dystroglycan","volume":"93","author":"Carss","year":"2013","journal-title":"Am J Hum Genet"},{"issue":"9","key":"10.1016\/j.nmd.2021.07.400_bib0050","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/brain\/awv185","article-title":"Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorder with dystroglycanopathies","volume":"138","author":"Belaya","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2021.07.400_bib0051","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/brain\/awt010","article-title":"Congenital myasthenic syndromes due to mutations in ALG2 and ALG14","volume":"136","author":"Cossins","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2021.07.400_bib0052","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13023-014-0174-9","article-title":"Severe dystonia, cerebellar atrophy, and cardiomyopathy likely caused by a missense mutation in TOR1AIP1","volume":"9","author":"Dorboz","year":"2014","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.nmd.2021.07.400_bib0053","doi-asserted-by":"crossref","first-page":"fcaa174","DOI":"10.1093\/braincomms\/fcaa174","article-title":"Congenital myasthenic syndrome due to a TOR1AIP1 mutation: a new disease pathway for impaired synaptic transmission","volume":"2","author":"Cossins","year":"2020","journal-title":"Brain Commun"},{"issue":"12","key":"10.1016\/j.nmd.2021.07.400_bib0054","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.nmd.2014.07.005","article-title":"Congenital myopathies with secondary neuromuscular transmission defects; a case report and review of the literature","volume":"24","author":"Rodr\u00edguez Cruz","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2021.07.400_bib0055","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.nmd.2011.03.002","article-title":"Endplate structure and parameters of neuromuscular transmission in sporadic centronuclear myopathy associated with myasthenia","volume":"21","author":"Liewluck","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2021.07.400_bib0056","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1086\/506257","article-title":"Escobar syndrome is a prenatal myasthenia caused by disruption of the acetylcholine receptor fetal gamma subunit","volume":"79","author":"Hoffmann","year":"2006","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.nmd.2021.07.400_bib0057","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.conb.2005.12.003","article-title":"Assembly of the postsynaptic membrane at the neuromuscular junction: paradigm lost","volume":"16","author":"Kummer","year":"2006","journal-title":"Curr Opin Neurobiol"},{"issue":"12","key":"10.1016\/j.nmd.2021.07.400_bib0058","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1093\/brain\/awz322","article-title":"\u03b22-Adrenergic receptor agonists ameliorate the adverse effect of long-term pyridostigmine on neuromuscular junction structure","volume":"142","author":"Vanhaesebrouck","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2021.07.400_bib0059","first-page":"341","article-title":"Update on treatment options for Lambert\u2013Eaton myasthenic syndrome: focus on use of amifampridine","volume":"7","author":"Lindquist","year":"2011","journal-title":"Neuropsychiatr Disord Treat"},{"key":"10.1016\/j.nmd.2021.07.400_bib0060","doi-asserted-by":"crossref","unstructured":"C.M. Harper, T. Fukodome, A.G. Engel Treatment of slow-channel congenital myasthenic syndrome with fluoxetine.Neurology 2003;60: 1710\u20133.","DOI":"10.1212\/01.WNL.0000061483.11417.1B"},{"key":"10.1016\/j.nmd.2021.07.400_bib0061","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1212\/WNL.0b013e3181dd43bf","article-title":"Ephedrine treatment in congenital Myasthenic syndrome due to mutations in DOK7","volume":"74","author":"Lashley","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2021.07.400_bib0062","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.nurt.2008.07.003","article-title":"Therapeutic strategies in congenital myasthenic syndromes","volume":"5","author":"Schara","year":"2008","journal-title":"Neurotherapeutics"},{"issue":"6203","key":"10.1016\/j.nmd.2021.07.400_bib0063","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1126\/science.1250744","article-title":"DOK7 gene therapy benefits mouse models of diseases characterized by defects in the neuromuscular junction","volume":"345","author":"Arimura","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.nmd.2021.07.400_bib0064","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-021-03672-3","article-title":"Mechanism of disease and therapeutic rescue of Dok7 congenital myasthenia","author":"Oury","year":"2021","journal-title":"Nature"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896621005885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896621005885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:11:24Z","timestamp":1760775084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896621005885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":64,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0960896621005885"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2021.07.400","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Congenital myasthenic syndromes: where do we go from here?","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2021.07.400","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}